12th Clinical Biomarker & Cdx Summit Europe
27
Apr
-
28
Apr
2022
When
London 
UK
Where

As the precision medicine industry witnesses exciting Drug-Dx approvals being driven by major advancements in biomarker development, the 12th Clinical Biomarker & CDx Summit Europe returns in 2022 to set the stage for key learnings with exclusive data to optimise your drug development programmes with the most cutting-edge tools and techniques from

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

27 - 28 Apr 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

CEO and President
Senior Specialist (Cdx)
Chief Scientific Officer
Head of Precision Medicine, Biopharmaceuticals
Global Regulatory Strategist – Ivd
Executive Director, Regulatory Affairs, Companion Diagnostics & Precision Medicine

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Medable, Inc

Medable's mission is to get effective therapies to patients faster.

Almac Group

A unique culture delivering exceptional solutions:
Almac is a financially secure, privately owned organisation with over 6,000 employees located within the US, Europe and Asia. 600+ companies worldwide, including all the market leaders, use ou

Illumina

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago.

Tempus Labs, Inc.

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.

Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics.

Natera

Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology.

SOPHiA GENETICS

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing.

NeoGenomics Laboratories

"NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years.

Q² Solutions

Q² Solutions is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biospecimen and consent management solutions.

Panakeia

Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer

Sengenics

Sengenics is a functional proteomics company that leverages its patented KREX protein folding technology to discover autoantibody biomarker signature for drug response prediction, patient stratification and development of companion diagnostics.

Radiomics

Radiomics is a next generation Liege-based imaging research organization built upon the unparallel experience of its founders, pioneers of the radiomics science.

Genialis

Advance your drug program from the lab through the clinic with Genialis.

Stilla Technologies

About Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic a

ARC Regulatory

ARC is a Medical Device consultancy and Clinical Research Organisation that specialises in delivering compliance excellence for companies in the IVD and Companion Diagnostics (CDx) sectors.

Veracyte IO, Immuno-oncology diagnostic products and services

Veracyte is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases.

Organizer

Get emails from us

Thank you
Oops! Something went wrong